![Bis[2-(4-hydroxyphenylthio)ethoxy]methane](https://file.medchemexpress.com/product_pic/hy-w744923.gif "Click to View Bis[2-(4-hydroxyphenylthio)ethoxy]methane Product Detail")
Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
12 Results for "
chicken embryos
" in MedChemExpress (MCE) Product Catalog:
Products (12)
12 Results for "chicken embryos" in MCE Product Catalog:
Cat. No.: HY-N6726
CAS No.: 1422359-85-0
Target:
Cat. No.: HY-N8492
CAS No.: 13283-90-4
Target:
Cat. No.: HY-N6726S
CAS No.: 2819816-90-3
Cat. No.: HY-N12201
CAS No.: 11055-06-4
Category:
Target:
Category:
Target:
Cat. No.: HY-W744923
CAS No.: 93589-69-6
Synonyms: DD-70
Target:
Research Areas:
Bis[2-(4-hydroxyphenylthio) ethoxy]methane (DD-70) is a Bisphenol A (HY-18260) substitute and a COX-1 inhibitor. Bis[2-(4-hydroxyphenylthio) ethoxy]methane blocks platelet aggregation induced by Arachidonic acid (HY-109590) and U-46619 (HY-108566). Bis[2-(4-hydroxyphenylthio) ethoxy]methane alters hemostatic function. Bis[2-(4-hydroxyphenylthio) ethoxy]methane reduces embryonic survival rate, decreases embryonic mass and increases gallbladder mass in chicken embryos .
Cat. No.: HY-178453
VEGFR-2-IN-74 (compound 55) is a potent VEGFR-2 inhibitor (IC50 = 0.035 µM). VEGFR-2-IN-74 exhibits good anti proliferative activity and can induce apoptosis in various cancer cells, such as A549 (IC50 = 2.67 µM) and HCT116 (IC50 = 10.87 µM) cells. VEGFR-2-IN-74 has low toxicity to normal cells. VEGFR-2-IN-74 shows significant anti angiogenic effects in chicken embryo models. VEGFR-2-IN-74 can be used in the research of cancer .
Cat. No.: HY-N6726R
CAS No.: 1422359-85-0
Category:
Cat. No.: HY-N6726S1
CAS No.: 1217494-88-6
Cat. No.: HY-178921
CAS No.: 1313741-00-2
Target:
Research Areas:
HJ-4 is a Piperine (HY-N0144) derivative. HJ-4 potently inhibits the proliferation of CRC cells by dose-dependently reducing colony formation and DNA synthesis. HJ-4 markedly suppresses the adhesion, migration, invasion and induces apoptosis of CRC cells. HJ-4 demonstrates anti-tumor efficacy in chicken embryo chorioallantoic membrane (CAM) model implanted with HCT116/SW480 tumor spheroids. HJ-4 can be used for the study of colorectal cancer (CRC) .
Cat. No.: HY-W1139983
CAS No.: 17479-04-8
Research Areas:
UDP-Glucosamine is a sugar nucleotide analog, glycosyl donor, and metabolite of D-galactosamine (HY-42682). UDP-Glucosamine provides Glucosamine (HY-B1125) for the synthesis of Dolichyl monophosphate glucosamine, inhibits the synthesis of Dolichyl monophosphate glucose, Dolichyl monophosphate mannose, and Dolichyl pyrophosphate (GlcNAc)2, sequesters Dolichyl monophosphate, and acts as a glycosyl donor in chicken embryo and rat liver microsomal preparations. UDP-Glucosamine can be used in studies related to influenza virus infection .
Cat. No.: HY-180814
Target:
Research Areas:
SKF-83566-PEG1-pomalidomide is an anti-tumor agent and is formed by the covalent connection of SKF-83566 (HY-103430A) (dopamine D1 receptor antagonist) and Pomalidomide (HY-10984) (immunomodulatory agent). SKF-83566-PEG1-pomalidomide can inhibit cancer cells invasion, migration and colony formation. SKF-83566-PEG1-pomalidomide can inhibit tumor growth and angiogenesis in MDA-MB-231 cell chicken embryo chorioallantoic membrane (CAM) xenograft model. SKF-83566-PEG1-pomalidomide can be used for research of breast cancer .
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
